(Q40979109)

25 September 2017

1 reference

title

Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study (English)

1 reference

25 September 2017

1 reference

1 reference

2

Folsom AR

1 reference

25 September 2017

Shahar E

1

1 reference

25 September 2017

Romm FJ

3

1 reference

25 September 2017

Bisgard KM

4

1 reference

25 September 2017

Metcalf PA

5

1 reference

25 September 2017

Crum L

6

1 reference

25 September 2017

McGovern PG

7

1 reference

25 September 2017

Hutchinson RG

8

1 reference

25 September 2017

Heiss G

9

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

25 September 2017

published in

American Heart Journal

1 reference

25 September 2017

volume

131

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

915-922

1 reference

The Use of Aspirin in Ischemic Heart Disease

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

An Overview of the British and American Aspirin Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

The primary prevention of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

The recent trials for aspirin in the prevention of cardiovascular mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

The Physician's Health Study. A neurologist's concern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Proportion of disease caused or prevented by a given exposure, trait or intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Use of aspirin for prevention of cardiovascular disease--1981-82 to 1985-86: the Minnesota Heart Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Prognosis and management after a first myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Comparison of “Rose questionnaire angina” to exercise thallium scintigraphy: Different findings in males and females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990173-8

10.1016/S0002-8703(96)90173-8

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference